Chemoinformaics analysis of 5-Methoxythiazole
| Molecular Weight | 115.157 | nRot | 1 |
| Heavy Atom Molecular Weight | 110.117 | nRig | 5 |
| Exact Molecular Weight | 115.009 | nRing | 1 |
| Solubility: LogS | -0.075 | nHRing | 1 |
| Solubility: LogP | 1.117 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 12 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 5 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 5 |
| nHA | 3 | APOL | 14.816 |
| nHD | 0 | BPOL | 10.352 |
| QED | 0.547 |
| Synth | 3.212 |
| Natural Product Likeliness | -0.798 |
| NR-PPAR-gamma | 0.023 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.143 |
| MDCK | 0.0000493 |
| BBB | 0.642 |
| PPB | 0.332633 |
| VDSS | 1.181 |
| FU | 0.60257 |
| CYP1A2-inh | 0.851 |
| CYP1A2-sub | 0.959 |
| CYP2c19-inh | 0.444 |
| CYP2c19-sub | 0.807 |
| CYP2c9-inh | 0.063 |
| CYP2c9-sub | 0.398 |
| CYP2d6-inh | 0.832 |
| CYP2d6-sub | 0.388 |
| CYP3a4-inh | 0.18 |
| CYP3a4-sub | 0.54 |
| CL | 9.565 |
| T12 | 0.837 |
| hERG | 0.016 |
| Ames | 0.308 |
| ROA | 0.499 |
| SkinSen | 0.914 |
| Carcinogencity | 0.628 |
| EI | 0.978 |
| Respiratory | 0.878 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.898727 |